The device combines tumescent local anesthesia infiltration, power-assisted tissue removal, and aspiration into a single platform.
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Nouvag AG for LipoSurg ARTIST, a power-assisted liposuction system developed for aesthetic body contouring.
The device integrates the infiltration of tumescent local anesthesia, power-assisted liposuction, and aspiration into a single platform, according to a release from Nouvag. The company developed the integrated system to align with modern aesthetic surgical workflows and operative demands.
“FDA clearance of LipoSurg ARTIST marks an important milestone for Nouvag and the beginning of a new chapter for us in the United States,” according to the release from Nouvag. “ARTIST was developed with one clear idea: Technology should follow the need of the surgeon, not the other way around. We are excited to finally bring that vision to the US market.”
Workflow Integration and Company Background
According to the company, the system represents a new generation of aesthetic technology developed from more than 50 years of experience in powered surgical equipment.
Headquartered in Goldach, Switzerland, Nouvag has manufactured and developed powered systems and surgical tools since 1971, according to the release. The company’s portfolio is distributed worldwide for applications in aesthetic surgery, general operating suites, and other medical specialties.
